Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robyn Guymer

Showing results (11-20 of 87) with videos related to

Pageof 9
Sort By:
Survey of Ophthalmology|December 1, 2006
Unraveling a complex genetic disease: age-related macular degenerationMatt Chamberlain, Paul Baird, Mohamed Dirani, et al.
Journal of Clinical Medicine|April 13, 2023
Performance of a Smart Device over 12-Months for Home Monitoring of Patients with Intermediate Age-Related Macular DegenerationSelwyn Prea, Robyn Guymer, George Kong, et al.
Ophthalmology and Therapy|September 29, 2023
Biomarkers for the Progression of Intermediate Age-Related Macular DegenerationEleonora M Lad, Robert P Finger, Robyn Guymer
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 6, 2003
Visual impairment caused by retinal abnormalities in mesangiocapillary (membranoproliferative) glomerulonephritis type II ("dense deposit disease")Deb Colville, Robyn Guymer, Roger A Sinclair, et al.
Clinical & Experimental Ophthalmology|October 25, 2013
Lessons learnt inform our approach to new antivascular endothelial growth factor treatments for neovascular age-related macular degenerationSanjeewa Wickremasinghe, Farshad Abedi, Sukhpal S Sandhu, et al.
Oman Journal of Ophthalmology|April 3, 2023
<i>De novo</i> choroidal osteoma after laser photocoagulation of a peripapillary choroidal neovascular membraneOmar Salehi, C Alex Harper, Robyn Guymer, et al.
Clinical & Experimental Ophthalmology|October 19, 2011
Ranibizumab therapy for choroidal neovascularization secondary to non-age-related macular degeneration causesRobyn Troutbeck, Roland Bunting, Anton van Heerdon, et al.
Clinical & Experimental Ophthalmology|March 17, 2007
Analysis of the RDS/peripherin gene in age-related macular degenerationPaul N Baird, Andrea Richardson, Amirul Islam, et al.
Ophthalmology Science|April 17, 2025
Real-World Evidence for Faricimab in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: A Scoping ReviewVarun Chaudhary, Robyn Guymer, Audrey Artignan, et al.
Ophthalmology|February 22, 2020
Anti-Vascular Endothelial Growth Factor Use and Atrophy in Neovascular Age-Related Macular Degeneration: Systematic Literature Review and Expert OpinionSriniVas R Sadda, Robyn Guymer, Jordi M Monés, et al.
Pageof 9

Showing results (11-20 of 87) with videos related to

Sort By:
Pageof 9
Survey of Ophthalmology|December 1, 2006
Unraveling a complex genetic disease: age-related macular degenerationMatt Chamberlain, Paul Baird, Mohamed Dirani, et al.
Journal of Clinical Medicine|April 13, 2023
Performance of a Smart Device over 12-Months for Home Monitoring of Patients with Intermediate Age-Related Macular DegenerationSelwyn Prea, Robyn Guymer, George Kong, et al.
Ophthalmology and Therapy|September 29, 2023
Biomarkers for the Progression of Intermediate Age-Related Macular DegenerationEleonora M Lad, Robert P Finger, Robyn Guymer
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 6, 2003
Visual impairment caused by retinal abnormalities in mesangiocapillary (membranoproliferative) glomerulonephritis type II ("dense deposit disease")Deb Colville, Robyn Guymer, Roger A Sinclair, et al.
Clinical & Experimental Ophthalmology|October 25, 2013
Lessons learnt inform our approach to new antivascular endothelial growth factor treatments for neovascular age-related macular degenerationSanjeewa Wickremasinghe, Farshad Abedi, Sukhpal S Sandhu, et al.
Oman Journal of Ophthalmology|April 3, 2023
<i>De novo</i> choroidal osteoma after laser photocoagulation of a peripapillary choroidal neovascular membraneOmar Salehi, C Alex Harper, Robyn Guymer, et al.
Clinical & Experimental Ophthalmology|October 19, 2011
Ranibizumab therapy for choroidal neovascularization secondary to non-age-related macular degeneration causesRobyn Troutbeck, Roland Bunting, Anton van Heerdon, et al.
Clinical & Experimental Ophthalmology|March 17, 2007
Analysis of the RDS/peripherin gene in age-related macular degenerationPaul N Baird, Andrea Richardson, Amirul Islam, et al.
Ophthalmology Science|April 17, 2025
Real-World Evidence for Faricimab in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: A Scoping ReviewVarun Chaudhary, Robyn Guymer, Audrey Artignan, et al.
Ophthalmology|February 22, 2020
Anti-Vascular Endothelial Growth Factor Use and Atrophy in Neovascular Age-Related Macular Degeneration: Systematic Literature Review and Expert OpinionSriniVas R Sadda, Robyn Guymer, Jordi M Monés, et al.
Pageof 9